1
|
Li CS, Xu Y, Li J, Qin SH, Huang SW, Chen XM, Luo Y, Gao CT, Xiao JH. Ultramodern natural and synthetic polymer hydrogel scaffolds for articular cartilage repair and regeneration. Biomed Eng Online 2025; 24:13. [PMID: 39920742 PMCID: PMC11804105 DOI: 10.1186/s12938-025-01342-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2024] [Accepted: 01/20/2025] [Indexed: 02/09/2025] Open
Abstract
Articular cartilage injury is a serious bone disease that can result in disabilities. With the rapid increase in the aging population, this disorder has become an increasingly important public health issue. Recently, stem cell-based cartilage tissue engineering has emerged as a promising therapeutic option for treating articular cartilage damage. Cellular scaffolds, which are among three key elements of tissue engineering, play significant roles in the repair of damaged articular cartilage by regulating cellular responses and promoting cartilage tissue regeneration. Biological macromolecules are commonly used as scaffold materials owing to their unique properties. For example, natural and synthetic polymer hydrogel scaffolds can effectively mimic the microenvironment of the natural extracellular matrix; exhibit high cytocompatibility, biocompatibility, and biodegradability; and have attracted increasing attention in bone and cartilage tissue engineering and regeneration medicine. Several types of hydrogel scaffolds have been fabricated to treat articular cartilage abnormalities. This article outlines the recent progress in the field of hydrogel scaffolds manufactured from various biomaterials for repairing damaged articular cartilage, discusses their advantages and disadvantages, and proposes directions for their future development.
Collapse
Affiliation(s)
- Chun-Sheng Li
- Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China
| | - Yan Xu
- Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China
- Guizhou Provincial Key Laboratory of Medicinal Biotechnology and Research Center for Translational Medicine in Colleges and Universities, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China
| | - Juan Li
- National Engineering Research Center for Compounding and Modification of Polymer Materials, Guizhou Material Industrial Technology Research Institute, Guiyang, 550014, China
| | - Shu-Hao Qin
- Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China.
- National Engineering Research Center for Compounding and Modification of Polymer Materials, Guizhou Material Industrial Technology Research Institute, Guiyang, 550014, China.
| | - Shao-Wen Huang
- National Engineering Research Center for Compounding and Modification of Polymer Materials, Guizhou Material Industrial Technology Research Institute, Guiyang, 550014, China
| | - Xue-Mei Chen
- Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China
- Department of Pediatrics, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China
| | - Yi Luo
- Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China
- Guizhou Provincial Key Laboratory of Medicinal Biotechnology and Research Center for Translational Medicine in Colleges and Universities, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China
| | - Cheng-Tao Gao
- National Engineering Research Center for Compounding and Modification of Polymer Materials, Guizhou Material Industrial Technology Research Institute, Guiyang, 550014, China
| | - Jian-Hui Xiao
- Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China.
- Guizhou Provincial Key Laboratory of Medicinal Biotechnology and Research Center for Translational Medicine in Colleges and Universities, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China.
- Department of Pediatrics, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China.
| |
Collapse
|
2
|
Liao J, Gu Q, Liu Z, Wang H, Yang X, Yan R, Zhang X, Song S, Wen L, Wang Y. Edge advances in nanodrug therapies for osteoarthritis treatment. Front Pharmacol 2024; 15:1402825. [PMID: 39539625 PMCID: PMC11559267 DOI: 10.3389/fphar.2024.1402825] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2024] [Accepted: 09/25/2024] [Indexed: 11/16/2024] Open
Abstract
As global population and lifestyles change, osteoarthritis (OA) is becoming a major healthcare challenge world. OA, a chronic condition characterized by inflammatory and degeneration, often present with joint pain and can lead to irreversible disability. While there is currently no cure for OA, it is commonly managed using nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticoids, and glucosamine. Although these treatments can alleviate symptoms, it is difficult to effectively deliver and sustain therapeutic agents within joints. The emergence of nanotechnology, particularly in form of smart nanomedicine, has introduced innovative therapeutic approaches for OA treatment. Nanotherapeutic strategies offer promising advantages, including more precise targeting of affected areas, prolonged therapeutic effects, enhanced bioavailability, and reduced systemic toxicity compared to traditional treatments. While nanoparticles show potential as a viable delivery system for OA therapies based on encouraging lab-based and clinical trials results, there remails a considerable gap between current research and clinical application. This review highlights recent advances in nanotherapy for OA and explore future pathways to refine and optimize OA treatments strategies.
Collapse
Affiliation(s)
- Jinfeng Liao
- Department of Dermatology, Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China
| | - Qingjia Gu
- Department of ENT, Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China
| | - Zheng Liu
- Department of Neuroscience, Baylor College of Medicine, Houston, TX, United States
| | - Hailian Wang
- Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Center of Organ Transplantation, Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China
| | - Xian Yang
- Department of Critical Care Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
| | - Rongkai Yan
- Department of Radiology, Ohio state university, Columbus, OH, United States
| | - Xiaofeng Zhang
- Greenwich Hospital, Yale New Haven Health, Greenwich, CT, United States
| | - Siyuan Song
- Department of Neuroscience, Baylor College of Medicine, Houston, TX, United States
| | - Lebin Wen
- Department of Thyroid, Sichuan Second Hospital of TCM, Chengdu, China
| | - Yi Wang
- Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Center of Organ Transplantation, Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China
- Department of Critical Care Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
| |
Collapse
|
3
|
Farasati
Far B, Safaei M, Nahavandi R, Gholami A, Naimi-Jamal MR, Tamang S, Ahn JE, Ramezani Farani M, Huh YS. Hydrogel Encapsulation Techniques and Its Clinical Applications in Drug Delivery and Regenerative Medicine: A Systematic Review. ACS OMEGA 2024; 9:29139-29158. [PMID: 39005800 PMCID: PMC11238230 DOI: 10.1021/acsomega.3c10102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/17/2023] [Revised: 03/28/2024] [Accepted: 04/02/2024] [Indexed: 07/16/2024]
Abstract
Hydrogel encapsulation is a promising carrier for cell and drug delivery due to its ability to protect the encapsulated entities from harsh physiological conditions and enhance their therapeutic efficacy and bioavailability. However, there is not yet consensus on the optimal hydrogel type, encapsulation method, and clinical application. Therefore, a systematic review of hydrogel encapsulation techniques and their potential for clinical application is needed to provide a comprehensive and up-to-date overview. In this systematic review, we searched electronic databases for articles published between 2008 and 2023 that described the encapsulation of cells or drug molecules within hydrogels. Herein, we identified 9 relevant studies that met the inclusion and exclusion criteria of our study. Our analysis revealed that the physicochemical properties of the hydrogel, such as its porosity, swelling behavior, and degradation rate, play a critical role in the encapsulation of cells or drug molecules. Furthermore, the encapsulation method, including physical, chemical, or biological methods, can affect the encapsulated entities' stability, bioavailability, and therapeutic efficacy. Challenges of hydrogel encapsulation include poor control over the release of encapsulated entities, limited shelf life, and potential immune responses. Future directions of hydrogel encapsulation include the development of novel hydrogel and encapsulation methods and the integration of hydrogel encapsulation with other technologies, such as 3D printing and gene editing. In conclusion, this review is useful for researchers, clinicians, and policymakers who are interested in this field of drug delivery and regenerative medicine that can serve as a guide for the future development of novel technologies that can be applied into clinical practice.
Collapse
Affiliation(s)
- Bahareh Farasati
Far
- Department
of Chemistry, Iran University of Science
and Technology, Tehran 13114-16846, Iran
| | - Maryam Safaei
- Department
of Pharmacology, Faculty of Pharmacy, Eastern
Mediterranean University, via Mersin 10, Famagusta, TR. North Cyprus 99628, Turkey
| | - Reza Nahavandi
- School
of Chemical Engineering, College of Engineering, University of Tehran, Tehran 1417935840, Iran
| | - Amir Gholami
- Faculty
of Medicine, Kurdistan University of Medical
Science, Sanandaj 6618634683, Iran
| | | | - Sujina Tamang
- NanoBio
High-Tech Materials Research Center, Department of Biological Sciences
and Bioengineering, Inha University, Incheon, 402-751, Republic of Korea
| | - Jung Eun Ahn
- NanoBio
High-Tech Materials Research Center, Department of Biological Sciences
and Bioengineering, Inha University, Incheon, 402-751, Republic of Korea
| | - Marzieh Ramezani Farani
- NanoBio
High-Tech Materials Research Center, Department of Biological Sciences
and Bioengineering, Inha University, Incheon, 402-751, Republic of Korea
| | - Yun Suk Huh
- NanoBio
High-Tech Materials Research Center, Department of Biological Sciences
and Bioengineering, Inha University, Incheon, 402-751, Republic of Korea
| |
Collapse
|
4
|
Almeida-Bezerra JW, Pereira da Cruz R, Bezerra da Silva V, Da Silva Neto JX, Alves Lopes de Souza L, de Oliveira Bezerra de Sousa D, Monteiro Salgueiro Araujo N, Guimarães Gomes Silva R, Quefi B, Rau M, Andrade Rebelo R, Castro Dos Santos S, Everson da Silva L, Douglas Melo Coutinho H, Almeida Menezes S, Bezerra Morais-Braga MF, Morais de Oliveira AF. Exploring the Fluconazole-Resistance Modifying Activity and Potential Mechanism of Action of Fixed Oil from Caryocar coriaceum Wittm. (Caryocaraceae) against Candida Species. Chem Biodivers 2024; 21:e202301960. [PMID: 38196022 DOI: 10.1002/cbdv.202301960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2023] [Revised: 01/09/2024] [Accepted: 01/09/2024] [Indexed: 01/11/2024]
Abstract
The fixed oil from the inner mesocarp of Caryocar coriaceum Wittm. is used in the Chapada do Araripe region of Brazil for the treatment of genitourinary candidiasis. This study aimed to evaluate the chemical composition, antifungal activity, reduction of fungal virulence, and the preliminary toxicity of the fixed oil from the inner mesocarp of C. coriaceum tested against three Candida yeasts. The oil was characterized by gas chromatography (GC-MS and GC-FID). Antifungal activity was assessed using the serial microdilution method. Additionally, the potential of the oil as an enhancer of fluconazole action was tested at sub-inhibitory concentrations (MIC/8). The mechanism of action of C. coriaceum fixed oil was determined by evaluating the inhibition of morphological transition in Candida spp. The chemical composition of the fixed oil of C. coriaceum comprised both unsaturated and saturated fatty acids. Oleic (61 %) and palmitic (33 %) acids were the major constituents. Regarding its anti-Candida activity, the oil inhibited the growth of C. albicans (IC50 : 371 μg/mL) and C. tropicalis (IC50 : 830 μg/mL). Furthermore, the oil reversed the antifungal resistance of C. albicans and C. tropicalis, restoring the susceptibility to fluconazole and reducing their IC50 from 12.33 μg/mL and 362 μg/mL to 0.22 μg/mL and 13.93 μg/mL, respectively. The fixed oil of C. coriaceum completely inhibited the morphological transition of C. albicans and C. tropicalis at a concentration of 512 μg/mL, but exhibited limited low antifungal potential against C. krusei. The observed antifungal activity may be attributed to the overproduction of reactive oxygen species. Additionally, the oil showed no toxic effect on the Drosophila melanogaster in vivo model. The fixed oil from the inner mesocarp of C. coriaceum emerge as a strong candidate for the development of new pharmaceutical formulations to treat infections caused by Candida spp.
Collapse
Affiliation(s)
- José Weverton Almeida-Bezerra
- Department of Botany, Federal University of Pernambuco-UFPE, s/n, Rua Professor Moraes Rego, Recife, Pernambuco, 50.670-901, Brazil
| | - Rafael Pereira da Cruz
- Department of Biological Sciences, Regional University of Cariri-URCA, 1161, Rua Cel. Antônio Luiz, Crato, Ceará, 63.105-000, Brazil
| | - Viviane Bezerra da Silva
- Department of Biological Sciences, Regional University of Cariri-URCA, 1161, Rua Cel. Antônio Luiz, Crato, Ceará, 63.105-000, Brazil
| | - João Xavier Da Silva Neto
- Department of Biochemistry and Molecular Biology, Federal University of Ceara'-UFC, s/n, Av. Humberto Monte, Fortaleza, 60.451-970, Brazil
| | - Larissa Alves Lopes de Souza
- Department of Biochemistry and Molecular Biology, Federal University of Ceara'-UFC, s/n, Av. Humberto Monte, Fortaleza, 60.451-970, Brazil
| | | | - Nadine Monteiro Salgueiro Araujo
- Department of Biochemistry and Molecular Biology, Federal University of Ceara'-UFC, s/n, Av. Humberto Monte, Fortaleza, 60.451-970, Brazil
| | - Rafael Guimarães Gomes Silva
- Department of Biochemistry and Molecular Biology, Federal University of Ceara'-UFC, s/n, Av. Humberto Monte, Fortaleza, 60.451-970, Brazil
| | - Blasco Quefi
- Department of Chemistry, Regional University of Blumenau, FURB, Itoupava Seca, 89030-903, Blumenau, SC, Brazil
| | - Martinho Rau
- Department of Chemistry, Regional University of Blumenau, FURB, Itoupava Seca, 89030-903, Blumenau, SC, Brazil
| | - Ricardo Andrade Rebelo
- Department of Chemistry, Regional University of Blumenau, FURB, Itoupava Seca, 89030-903, Blumenau, SC, Brazil
| | - Sarah Castro Dos Santos
- Department of Chemistry, Regional University of Blumenau, FURB, Itoupava Seca, 89030-903, Blumenau, SC, Brazil
| | - Luiz Everson da Silva
- Postgraduate Program in Sustainable Territorial Development, Coastal Sector, Federal University of Paraná, Matinhos, PR, Brazil
| | - Henrique Douglas Melo Coutinho
- Department of Biological Chemistry, Regional University of Cariri-URCA, 1161, Rua Cel. Antônio Luiz, Crato, Ceará, 63.105-000, Brazil
| | - Saulo Almeida Menezes
- Center of Biotechnology, Federal University of Rio Grande do Sul-UFRGS, 9500, Av. Bento Gonçalves, Porto Alegre, Rio Grande do Sul, 91501-970, Brazil
| | | | | |
Collapse
|
5
|
Qi W, Zhang R, Wang Z, Du H, Zhao Y, Shi B, Wang Y, Wang X, Wang P. Advances in the Application of Black Phosphorus-Based Composite Biomedical Materials in the Field of Tissue Engineering. Pharmaceuticals (Basel) 2024; 17:242. [PMID: 38399457 PMCID: PMC10892510 DOI: 10.3390/ph17020242] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2024] [Revised: 02/07/2024] [Accepted: 02/07/2024] [Indexed: 02/25/2024] Open
Abstract
Black Phosphorus (BP) is a new semiconductor material with excellent biocompatibility, degradability, and optical and electrophysical properties. A growing number of studies show that BP has high potential applications in the biomedical field. This article aims to systematically review the research progress of BP composite medical materials in the field of tissue engineering, mining BP in bone regeneration, skin repair, nerve repair, inflammation, treatment methods, and the application mechanism. Furthermore, the paper discusses the shortcomings and future recommendations related to the development of BP. These shortcomings include stability, photothermal conversion capacity, preparation process, and other related issues. However, despite these challenges, the utilization of BP-based medical materials holds immense promise in revolutionizing the field of tissue repair.
Collapse
Affiliation(s)
- Wanying Qi
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (W.Q.); (R.Z.)
| | - Ru Zhang
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (W.Q.); (R.Z.)
| | - Zaishang Wang
- School of Pharmacy, Guilin Medical University, Guilin 541001, China;
| | - Haitao Du
- Shandong Academy of Chinese Medicine, Jinan 250014, China; (H.D.); (Y.Z.); (Y.W.)
| | - Yiwu Zhao
- Shandong Academy of Chinese Medicine, Jinan 250014, China; (H.D.); (Y.Z.); (Y.W.)
| | - Bin Shi
- Shandong Medicinal Biotechnology Center, Jinan 250062, China;
| | - Yi Wang
- Shandong Academy of Chinese Medicine, Jinan 250014, China; (H.D.); (Y.Z.); (Y.W.)
| | - Xin Wang
- State Key Laboratory of Biobased Material and Green Papermaking, Faculty of Light Industry, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, China
| | - Ping Wang
- Shandong Academy of Chinese Medicine, Jinan 250014, China; (H.D.); (Y.Z.); (Y.W.)
| |
Collapse
|
6
|
Silva VRP, Pinheiro AC, Ombredane AS, Martins NO, Luz GVS, Carneiro MLB, Joanitti GA. Anti-Inflammatory Activity of Pequi Oil ( Caryocar brasiliense): A Systematic Review. Pharmaceuticals (Basel) 2023; 17:11. [PMID: 38275996 PMCID: PMC10821120 DOI: 10.3390/ph17010011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2023] [Revised: 11/04/2023] [Accepted: 11/08/2023] [Indexed: 01/27/2024] Open
Abstract
Disorders in the inflammatory process underlie the pathogenesis of numerous diseases. The utilization of natural products as anti-inflammatory agents is a well-established approach in both traditional medicine and scientific research, with studies consistently demonstrating their efficacy in managing inflammatory conditions. Pequi oil, derived from Caryocar brasiliense, is a rich source of bioactive compounds including fatty acids and carotenoids, which exhibit immunomodulatory potential. This systematic review aims to comprehensively summarize the scientific evidence regarding the anti-inflammatory activity of pequi oil. Extensive literature searches were conducted across prominent databases (Scopus, BVS, CINAHL, Cochrane, LILACS, Embase, MEDLINE, ProQuest, PubMed, FSTA, ScienceDirect, and Web of Science). Studies evaluating the immunomodulatory activity of crude pequi oil using in vitro, in vivo models, or clinical trials were included. Out of the 438 articles identified, 10 met the stringent inclusion criteria. These studies collectively elucidate the potential of pequi oil to modulate gene expression, regulate circulating levels of pro- and anti-inflammatory mediators, and mitigate oxidative stress, immune cell migration, and cardinal signs of inflammation. Moreover, negligible to no toxicity of pequi oil was observed across the diverse evaluated models. Notably, variations in the chemical profile of the oil were noted, depending on the extraction methodology and geographical origin. This systematic review strongly supports the utility of pequi oil in controlling the inflammatory process. However, further comparative studies involving oils obtained via different methods and sourced from various regions are warranted to reinforce our understanding of its effectiveness and safety.
Collapse
Affiliation(s)
- Vitória R. P. Silva
- Laboratory of Bioactive Compounds and Nanobiotechnology (LBCNano), Faculty of Ceilandia, University of Brasilia, Centro Metropolitano, Ceilândia Sul, Brasilia 72220-275, DF, Brazil; (V.R.P.S.); (A.C.P.); (A.S.O.); (N.O.M.); (M.L.B.C.)
- Post-Graduate Program in Pharmaceuticals Sciences, Faculty of Health Sciences, University of Brasilia, Campus Darcy Ribeiro, Brasilia 70910-900, DF, Brazil
| | - Andréia C. Pinheiro
- Laboratory of Bioactive Compounds and Nanobiotechnology (LBCNano), Faculty of Ceilandia, University of Brasilia, Centro Metropolitano, Ceilândia Sul, Brasilia 72220-275, DF, Brazil; (V.R.P.S.); (A.C.P.); (A.S.O.); (N.O.M.); (M.L.B.C.)
- Post-Graduation Program in Nanoscience and Nanobiotechnology, Institute of Biological Sciences, University of Brasilia, Campus Darcy Ribeiro, Brasilia 70910-900, DF, Brazil
| | - Alicia S. Ombredane
- Laboratory of Bioactive Compounds and Nanobiotechnology (LBCNano), Faculty of Ceilandia, University of Brasilia, Centro Metropolitano, Ceilândia Sul, Brasilia 72220-275, DF, Brazil; (V.R.P.S.); (A.C.P.); (A.S.O.); (N.O.M.); (M.L.B.C.)
| | - Natália Ornelas Martins
- Laboratory of Bioactive Compounds and Nanobiotechnology (LBCNano), Faculty of Ceilandia, University of Brasilia, Centro Metropolitano, Ceilândia Sul, Brasilia 72220-275, DF, Brazil; (V.R.P.S.); (A.C.P.); (A.S.O.); (N.O.M.); (M.L.B.C.)
| | - Glécia V. S. Luz
- Health Technology Assessment Center-NATS/UnB, University of Brasilia, Campus Darcy Ribeiro, Brasilia 70910-900, DF, Brazil;
- Post-Graduation Program in Biomedical Engineering, Faculty of Gama, University of Brasilia, Brasilia 72444-240, DF, Brazil
| | - Marcella L. B. Carneiro
- Laboratory of Bioactive Compounds and Nanobiotechnology (LBCNano), Faculty of Ceilandia, University of Brasilia, Centro Metropolitano, Ceilândia Sul, Brasilia 72220-275, DF, Brazil; (V.R.P.S.); (A.C.P.); (A.S.O.); (N.O.M.); (M.L.B.C.)
- Post-Graduation Program in Nanoscience and Nanobiotechnology, Institute of Biological Sciences, University of Brasilia, Campus Darcy Ribeiro, Brasilia 70910-900, DF, Brazil
- Post-Graduation Program in Biomedical Engineering, Faculty of Gama, University of Brasilia, Brasilia 72444-240, DF, Brazil
| | - Graziella A. Joanitti
- Laboratory of Bioactive Compounds and Nanobiotechnology (LBCNano), Faculty of Ceilandia, University of Brasilia, Centro Metropolitano, Ceilândia Sul, Brasilia 72220-275, DF, Brazil; (V.R.P.S.); (A.C.P.); (A.S.O.); (N.O.M.); (M.L.B.C.)
- Post-Graduation Program in Nanoscience and Nanobiotechnology, Institute of Biological Sciences, University of Brasilia, Campus Darcy Ribeiro, Brasilia 70910-900, DF, Brazil
| |
Collapse
|
7
|
Claro-Cala CM, Grao-Cruces E, Toscano R, Millan-Linares MC, Montserrat-de la Paz S, Martin ME. Acyclic Diterpene Phytol from Hemp Seed Oil ( Cannabis sativa L.) Exerts Anti-Inflammatory Activity on Primary Human Monocytes-Macrophages. Foods 2022; 11:foods11152366. [PMID: 35954130 PMCID: PMC9367727 DOI: 10.3390/foods11152366] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2022] [Revised: 07/31/2022] [Accepted: 08/05/2022] [Indexed: 11/18/2022] Open
Abstract
Seeds from non-drug varieties of hemp (Cannabis sativa L.) have been used for traditional medicine, food, and fiber production. Our study shows that phytol obtained from hemp seed oil (HSO) exerts anti-inflammatory activity in human monocyte-macrophages. Fresh human monocytes and human macrophages derived from circulating monocytes were used to evaluate both plasticity and anti-inflammatory effects of phytol from HSO at 10–100 mM using FACS analysis, ELISA, and RT-qPCR methods. The quantitative study of the acyclic alcohol fraction isolated from HSO shows that phytol is the most abundant component (167.59 ± 1.81 mg/Kg of HSO). Phytol was able to skew monocyte-macrophage plasticity toward the anti-inflammatory non-classical CD14+CD16++ monocyte phenotype and toward macrophage M2 (CD200Rhigh and MRC-1high), as well as to reduce the production of IL-1β, IL-6, and TNF-α, diminishing the inflammatory competence of mature human macrophages after lipopolysaccharide (LPS) treatment. These findings point out for the first time the reprogramming and anti-inflammatory activity of phytol in human monocyte-macrophages. In addition, our study may help to understand the mechanisms by which phytol from HSO contributes to the constant and progressive plasticity of the human monocyte-macrophage linage.
Collapse
Affiliation(s)
- Carmen M. Claro-Cala
- Department of Pharmacology, Pediatric and Radiology, Faculty of Medicine, Universidad de Sevilla, Av. Sanchez Pizjuan s/n, 41009 Seville, Spain
- Correspondence: ; Tel.: +34-954556083
| | - Elena Grao-Cruces
- Department of Medical Biochemistry, Molecular Biology and Immunology, School of Medicine, Universidad de Sevilla, Av. Sanchez Pizjuan s/n, 41009 Seville, Spain
| | - Rocio Toscano
- Department of Medical Biochemistry, Molecular Biology and Immunology, School of Medicine, Universidad de Sevilla, Av. Sanchez Pizjuan s/n, 41009 Seville, Spain
| | - Maria C. Millan-Linares
- Department of Medical Biochemistry, Molecular Biology and Immunology, School of Medicine, Universidad de Sevilla, Av. Sanchez Pizjuan s/n, 41009 Seville, Spain
| | - Sergio Montserrat-de la Paz
- Department of Medical Biochemistry, Molecular Biology and Immunology, School of Medicine, Universidad de Sevilla, Av. Sanchez Pizjuan s/n, 41009 Seville, Spain
| | - Maria E. Martin
- Department of Cell Biology, Faculty of Biology, Universidad de Sevilla, Av. Reina Mercedes s/n, 41012 Seville, Spain
| |
Collapse
|
8
|
Caponio GR, Lippolis T, Tutino V, Gigante I, De Nunzio V, Milella RA, Gasparro M, Notarnicola M. Nutraceuticals: Focus on Anti-Inflammatory, Anti-Cancer, Antioxidant Properties in Gastrointestinal Tract. Antioxidants (Basel) 2022; 11:antiox11071274. [PMID: 35883765 PMCID: PMC9312044 DOI: 10.3390/antiox11071274] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Revised: 06/21/2022] [Accepted: 06/24/2022] [Indexed: 02/07/2023] Open
Abstract
In recent years, nutraceuticals have gained great popularity, owing to their physiological and potential health effects, such as anti-inflammatory, anti-cancer, antioxidant, and prebiotic effects, and their regulation of lipid metabolism. Since the Mediterranean diet is a nutritionally recommended dietary pattern including high-level consumption of nutraceuticals, this review aimed to summarize the main results obtained by our in vitro and in vivo studies on the effects of the major constituents of the Mediterranean diet (i.e., extra virgin olive oil compounds, polyunsaturated fatty acids, and fruit components). Based on experimental studies, the therapeutic purpose of nutraceuticals depends on their bioavailability, solubility, toxicity, and delivery system. This review provides more in-depth knowledge on the effects linked to nutraceuticals administration on human health, focusing the gastrointestinal tract and suggesting specific dietary components for personalized adjuvant therapies.
Collapse
Affiliation(s)
- Giusy Rita Caponio
- National Institute of Gastroenterology “Saverio de Bellis”, Research Hospital, Castellana Grotte, 70013 Bari, Italy; (G.R.C.); (T.L.); (V.T.); (I.G.); (V.D.N.)
| | - Tamara Lippolis
- National Institute of Gastroenterology “Saverio de Bellis”, Research Hospital, Castellana Grotte, 70013 Bari, Italy; (G.R.C.); (T.L.); (V.T.); (I.G.); (V.D.N.)
| | - Valeria Tutino
- National Institute of Gastroenterology “Saverio de Bellis”, Research Hospital, Castellana Grotte, 70013 Bari, Italy; (G.R.C.); (T.L.); (V.T.); (I.G.); (V.D.N.)
| | - Isabella Gigante
- National Institute of Gastroenterology “Saverio de Bellis”, Research Hospital, Castellana Grotte, 70013 Bari, Italy; (G.R.C.); (T.L.); (V.T.); (I.G.); (V.D.N.)
| | - Valentina De Nunzio
- National Institute of Gastroenterology “Saverio de Bellis”, Research Hospital, Castellana Grotte, 70013 Bari, Italy; (G.R.C.); (T.L.); (V.T.); (I.G.); (V.D.N.)
| | - Rosa Anna Milella
- Research Centre for Viticulture and Enology, Council for Agricultural Research and Economics, Turi, 70010 Bari, Italy; (R.A.M.); (M.G.)
| | - Marica Gasparro
- Research Centre for Viticulture and Enology, Council for Agricultural Research and Economics, Turi, 70010 Bari, Italy; (R.A.M.); (M.G.)
| | - Maria Notarnicola
- National Institute of Gastroenterology “Saverio de Bellis”, Research Hospital, Castellana Grotte, 70013 Bari, Italy; (G.R.C.); (T.L.); (V.T.); (I.G.); (V.D.N.)
- Correspondence: ; Tel.: +39-080-4994342
| |
Collapse
|